Fundraising Fox

Reflexionmedical

Hayward, US · 7 known investors

Find your way into Reflexionmedical

1,290 people in our graph share verified history with the Reflexionmedical team — schools, employers, funds. One of them is your warm intro.

Paul Kwanunlockedknows Samuel Mazin · together at Stanford University (overlapped)
×6knows the team · via Stanford University
knows the team · via Stanford University Graduate School of Business
knows the team · via University of Waterloo
knows the team · via Cypress Semiconductor
×2knows the team · via Qualcomm

RefleXion Medical develops SCINTIX autonomous radiotherapy, an external beam theranostic oncology platform that uses biological signals from radiopharmaceutical-labeled cancer cells to deliver real-time, motion-managed radiation to lung and bone tumors from primary or metastatic disease. The technology is used by cancer treatment centers, including freestanding cancer centers and hospital outpatient departments, to treat solid tumors at any stage.

BiotechHealthtechMedical Devices

Founders & leadership

SM
Samuel MazininFounder and CTOCo-founder and executive officer of RefleXion Medical. He has expertise in medical imaging (CT, PET, MRI), medical device design, Monte Carlo simulation, and reconstruction algorithms.
ANAkshay Nanduri
Akshay NanduriinFounder, Vice President of Strategy & Business Development2009–2019

Board

JW
Jay WatkinsBoard director

Investors · 7

Ascension VenturesSaint Louis · $10M – $20M
Catalio Capital Management, LPNew York
Pfizer Venture Investments$5M – $20Mvia Rana Al-Hallaq · board
Sofinnova PartnersParis · $540K – $27M
Sonder CapitalSan Carlosvia Fred Moll · board
VenrockPalo Alto · $500K – $10M
Sonder FuturesreportedSan Francisco

Reported raises · per SEC filings

Form D private placements

$413M disclosed across 6 rounds · 2014–2023

▶$106.7MraisedNov 2023 · 43 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Samuel MazinExecutive Officer, Director
  • Diana KingExecutive Officer
  • Sean ShirvaniExecutive Officer
  • Cem UsakliDirector
  • Gopinath KuduvalliExecutive Officer
  • Martyn WebsterExecutive Officer
  • Art HeidrichDirector
  • Fred MollDirector
  • Jeffrey HolifieldExecutive Officer
  • Philip J. Aulson IIExecutive Officer
  • Rana Al-HallaqDirector
  • Kathy O'ShaughnessyExecutive Officer
  • David LarkinExecutive Officer
  • Judy Bartlett-RobertoExecutive Officer
  • Jay WatkinsDirector
  • Matthew T. HobartDirector
  • Renee RyanDirector
  • Thorsten MelcherExecutive Officer
  • Kevin ReillyDirector
  • Alice SchroederDirector
  • Greg GarfieldDirector
  • Todd PowellExecutive Officer, Director
  • Leena KadakiaExecutive Officer
  • Leonard LyonsExecutive Officer
Offering amount
$201.4M
Amount sold
$106.7M
First sale
Nov 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$80.7MraisedMar 2022 · 31 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Gopinath KuduvalliExecutive Officer
  • Rana Al-HallaqDirector
  • Matthew HobartDirector
  • Alice SchroederDirector
  • Cem UsakliDirector
  • David LarkinExecutive Officer
  • Thorsten MelcherExecutive Officer
  • Martyn WebsterExecutive Officer
  • Greg GarfieldDirector
  • Jeff HolifieldExecutive Officer
  • Judy Bartlett-RobertoExecutive Officer
  • Kathy O'ShaughnessyExecutive Officer
  • Antoine PapiernikDirector
  • David LeungExecutive Officer
  • Sean ShirvaniExecutive Officer
  • Fred MollDirector
  • Renee RyanDirector
  • Todd PowellExecutive Officer, Director
  • Philip J. Aulson IIExecutive Officer
  • Samuel MazinExecutive Officer, Director
  • Leonard LyonsExecutive Officer
  • Jay WatkinsDirector
Offering amount
$110M
Amount sold
$80.7M
First sale
Mar 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$100MraisedApr 2020 · 17 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Loic JuleDirector
  • Todd PowellExecutive Officer, Director
  • Bill BurkothDirector
  • Martyn WebsterExecutive Officer
  • Samuel MazinExecutive Officer, Director
  • Fred MollDirector
  • Matthew HobartDirector
  • Greg GarfieldDirector
  • Jay WatkinsDirector
  • Antoine PapiernikDirector
Offering amount
$125M
Amount sold
$100M
Sales commissions
$2M
Placement agents
Morgan Stanley & Co. LLC, BofA Securities, Inc.
First sale
Apr 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$96.5MraisedApr 2018 · 18 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • TODD POWELLExecutive Officer, Director
  • ANTOINE PAPIERNIKDirector
  • GREG GARFIELDDirector
  • MATTHEW HOBARTDirector
  • SAMUEL MAZINExecutive Officer, Director
  • JAY WATKINSDirector
  • FRED MOLLDirector
  • BILL BURKOTHDirector
Offering amount
$102.6M
Amount sold
$96.5M
First sale
Mar 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$23MraisedApr 2016 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • William BurkothDirector
  • Nael KassarDirector
  • Greg GarfieldDirector
  • Fred MollDirector
  • Akshay NanduriExecutive Officer, Director
  • Samuel MazinExecutive Officer, Director
  • Colin CahillDirector
  • Jay WatkinsDirector
  • Antoine PapiernikDirector
Offering amount
$52M
Amount sold
$23M
First sale
Apr 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.1MraisedApr 2014 · 19 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Akshay NanduriExecutive Officer, Director
  • Samuel MazinExecutive Officer, Director
  • Jay WatkinsDirector
Offering amount
$11.6M
Amount sold
$6.1M
Proceeds to insiders
$80K
First sale
Mar 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Reflexionmedical went on to found or lead other companies.

Adam KeatingMechanical Engineering Design & TestingFounded CoLabNaren YenugantiSoftware Engineer InternFounded Polymath

Frequently asked questions

What does Reflexionmedical do?
RefleXion Medical develops SCINTIX autonomous radiotherapy, an external beam theranostic oncology platform that uses biological signals from radiopharmaceutical-labeled cancer cells to deliver real-time, motion-managed radiation to lung and bone tumors from primary or metastatic disease. The technology is used by cancer treatment centers, including freestanding cancer centers and hospital outpatient departments, to treat solid tumors at any stage.
Who founded Reflexionmedical?
Reflexionmedical was founded by Samuel Mazin.
Who are Reflexionmedical's investors?
Reflexionmedical's investors include Ascension Ventures, Catalio Capital Management, LP, Pfizer Venture Investments, Sofinnova Partners, Sonder Capital, Venrock, Sonder Futures.
How much funding has Reflexionmedical raised?
Reflexionmedical has disclosed $413M raised across 6 rounds.
Where is Reflexionmedical headquartered?
Reflexionmedical is headquartered in Hayward, US.